Pharma Newsletter – September 18 to September 22, 2017

This week, “Zydus Cadila Healthcare announced on Thursday that the company received the final approval for Itraconazole Capsules from the USFDA, surging the company’s stock on the bourses’.

Sep 23, 2017 09:09 IST India Infoline News Service

Top News
 
Zydus receives final approval from USFDA for Itraconazole Capsules
 
Zydus Cadila Healthcare announced on Thursday that the company received the final approval for Itraconazole Capsules from the USFDA, surging the company’s stock on the bourses. Read More
 
Vivimed Lab receives GMP certification
 
The share price of Vivimed Lab shot up in the intraday trade on Thursday as the company announced that its Jeedimetla FDF plant bagged the approval of the Ukraine ministry of Health. Read More
 
Claris Lifesciences completes its stake sale in Otsuka Pharmaceuticals
 
Claris Lifesciences announced on Thursday that the company has completed the sale of its remaining 20% stake in Otsuka Pharmaceuticals India Private Limited. Read More
 
Orchid Pharma gets EIR from USFDA
 
Orchid Pharma has received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection of the Active Pharmaceutical Ingredients (API) manufacturing facility located at SIDCO Industrial Estate, Alathur, Kanchipuram District, Tamil Nadu, India. Read More

Related Story